PERSPECTIVE THERAPEUTICS, INC. Operating Leases, Future Minimum Payments, Due in Four Years
PERSPECTIVE THERAPEUTICS, INC. (CATX) had Operating Leases, Future Minimum Payments, Due in Four Years of $237.00 thousand as of 2017-06-30, per its 10-K filed 2017-09-28.
Discontinued › Notes › Leases
us-gaap:OperatingLeasesFutureMinimumPaymentsDueInFourYears · last filed 2017-09-28
- 2017-06-30: Operating Leases, Future Minimum Payments, Due in Four Years $237.00K.
- 2017-03-31: Operating Leases, Future Minimum Payments, Due in Four Years $281.00K.
- 2016-12-31: Operating Leases, Future Minimum Payments, Due in Four Years $281.00K.
- 2015-06-30: Operating Leases, Future Minimum Payments, Due in Four Years $232.38K.
| Period end | Operating Leases, Future Minimum Payments, Due in Four Years |
|---|---|
| 2017-06-30 | $237.00K 10-K · filed 2017-09-28 |
| 2017-03-31 | $281.00K 10-Q · filed 2017-05-10 |
| 2016-12-31 | $281.00K 10-Q · filed 2017-02-09 |
| 2015-06-30 | $232.38K 10-K · filed 2015-09-14 |
| 2014-06-30 | $277.22K 10-K · filed 2014-09-29 |
| 2013-06-30 | $270.80K 10-K · filed 2013-09-30 |
| 2012-06-30 | $238.51K 10-K/A · filed 2012-10-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Upstream Bio, Inc. (UPB) | United States | $0.284B | -2.42 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |
| Sagimet Biosciences Inc. (SGMT) | United States | $0.279B | |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| Mereo BioPharma Group plc (MREO) | $0.269B | -9.41 | |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| Greenwich LifeSciences, Inc. (GLSI) | United States | $0.267B | -15.02 |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |